... populations in the Columbia River may be declining due ... including DDT and polychlorinated biphenyls in their bodies, according ... , The research by Carl Schreck and Grant ... been published in the journals Environmental Health Perspectives and ...
... published by the journal Genome Research , a team ... a major force in human history, nor have been cannibalistic ... Prof. Jaume Bertranpetit, a scientist at the Universitat Pompeu ... data to show that balancing selection associated with cannibalism has ...
... the evolution of bees is how some species developed ... Gro Amdam thinks part of the answer can be ... paper describing Amdam's experiments, "Complex social behavior derived from ... current issue (Jan. 5, 2006) of Nature. Additional authors ...
Other Biology News:Contaminants linked to sturgeon decline in Columbia river 2History of human cannibalism eats away at researchers 2ASU researchers find link between social behavior, maternal traits in bees 2ASU researchers find link between social behavior, maternal traits in bees 3ASU researchers find link between social behavior, maternal traits in bees 4(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/11/2009)... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: ... of its previously announced public offering have exercised ... 2,250,000 shares of common stock at the public ... exercise of the option increases the size of ... of common stock. Dendreon expects to receive ...
(Date:12/11/2009)... 11 Algeta ASA (OSE: ALGETA), ... clinical center in the,US, the Tulane Cancer ... the phase III clinical study of Alpharadin ... prostate cancer,(CRPC) that has metastasized to the ... ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study ...
(Date:12/10/2009)... SEATTLE, Dec. 10 Dendreon Corporation (Nasdaq: ... underwritten public offering of 15,000,000 shares of its common ... per share. Dendreon also granted to the underwriters ... 2,250,000 shares of common stock to cover overallotments, if ... December 15, 2009, subject to customary closing conditions. ,, ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3... ... Symposium, ... TopSpin Medical (TASE: TOPMD) announced today that the 30-day results,from ... System During Coronary Endovascular,Catheterization (TOPIMAGE) demonstrated the safety and technical ...
... Oct. 22 BioMedical Enterprises, Inc.,(BME), a privately ... memory implant technology, today announced that the U.S. ... clearance to the,OSSpine(TM) for use in anterior fixation ... & bone graft retention. The patent-pending,OSSpine(TM) builds on ...
... (OTC Bulletin Board: AIDA) today announced an update,on its ... launched by,the Company into the China market. Aida previously ... in July 2006, which consists of tests,for safety, dosage ... II & III. Aida is currently undergoing Phase II ...
Other Biology Technology:Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries 2Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries 3BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 3Rabbit anti-NFkB p105/p50 (Ser529) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Anti-rat Dipeptidyl Peptidase IV (DPP IV), CD26, Clone 5E8, Monoclonal Antibody...
... Anti-acetyl-Histone H3 (Lys 4) ... the sequence ...RT[ Ac K]Q... in which ... 4 of human histone H3 ... Molecular Weight: Mr ~17kDa ...
Biology Products:Biology NavigationMedical Navigation